臺灣農藥科學 第
1
期
32
Pesticide Sex Endpoint
BM
4)
AIC SR
5)
P BMD BMDL
BMD/
BMDL
RN
6)
Propoxur NA Bladder
hyperplasia
LL 61 0
1
202 74
2.73 (54, 55)
Dicofol
NA Liver ad-
enoma
LL 83 0
1
22
15
1.47 (17)
NA Hepatocel-
luar carci-
noma
LL 197 -0.55 0.03 10
5
2
Etofen-
prox
NA Adrenal
vacuolation
LL 358 0.52 0.87 29
16
1.81 (29)
NA Adrenal
vacuolation
LL 197 -0.08 0.05 83
30
2.77
Fenari-
mol
NA Hyperpal-
stic nodule
LL 64 -0.14 0.46 5
3
1.67 (30)
NA Hepatic
adenoma
LL 33 -0.04 0.95 11
6
1.83
Bifen-
thrin
NA Bladder
leiomyosar-
coma
P 274 1.95 0
18
15
1.2
(5)
Flusila-
zole
NA Hepatocel-
lular vacu-
olation
LL 72 -0.59 0.90 27
11
2.45 (35)
NA Hepatocel-
lular vacu-
olation
LL 86 -0.09 0.60 12
7
1.71
NA Hydrone-
phrosis
G 221 -1.83 0
0.49 0.41 1.2
NA Liver acido-
philic foci
LL 153 0.01 0.97 5
2
2.5
NA Liver dif-
fuse fat
LL 266 0.05 0.88 2.25 1.12 2.01
表一、分析
31
種農藥之基準劑量與其最適模式、相關參數及資料來源(續)
Table 1.
Parameters and source of BMD analysis for the 31 pesticide risk assessment models
(continued)




